Halberd Corp HALB
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 707.30M
- Market Cap
- $1.20M
- Volume/Avg
- 555,830 / 751,731
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 3
Valuation
|
Metric
|
HALB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HALB
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | −65.02 |
Quick Ratio
HALB
Profitability
|
Metric
|
HALB
|
|---|---|
Return on Assets (Normalized) | −3,091.66% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
HALB
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|#cl$<Y^ | LOCK|XZ>! | $128B | |||
| Moderna Inc
MRNA
| LOCK|KWVv%m< | LOCK|@>& | $78B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|rR$j<&# | LOCK|y%!gQ | $76B | |||
| argenx SE ADR
ARGX
| LOCK|dWMhxv> | LOCK|LB$ | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|sgXqtm< | LOCK|N? | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|<y@b!&^ | LOCK|@vK## | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|&&BDkgj | LOCK|y#V>$ | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|@dTx%K | LOCK|ck | $24B | |||
| Incyte Corp
INCY
| LOCK|!z#&#% | LOCK|>p | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|&VQDfY | LOCK|Wt% | $15B |
United States